Autopsy report · NCT01955616
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
Cause of deathNo reason given
Life of this trial
- Ran for about 2 years before it stopped.
- 18 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Motus Therapeutics, Inc.
- Sponsor type
- Industry
- Conditions
- Parkinson's Disease
- Interventions
- RM-131; Placebo
- Participants
- 18
- Sites
- 13
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.